For immunochemical detection of MAP2
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

MAP2 (human) Polyclonal Antibody

Item No. 29282

Technical Information
Synonyms
  • MAP-2
  • Microtubule-associated Protein 2
Immunogen
Recombinant human MAP2 expressed in E. coli
MW
~280 kDa
100 µl of protein G-purified polyclonal antibody
Storage Buffer
PBS with 50% glycerol, and 5 mM sodium azide
Host
Goat
Applications
ICC, IHC, WB
Species Reactivity
(+) Human(+) Mouse(+) Rat
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Product Description

    Microtubule-associated protein 2 (MAP2) belongs to the microtubule-associated protein (MAP) family of cytoskeletal filament proteins, which includes MAP1-5 and tau.1 MAP2 is composed of an N-terminal projection domain that interacts with PKA and a C-terminal domain that contains microtubule binding repeats containing a KXGS motif that is subject to phosphorylation.2 Five isoforms of MAP2 are generated through alternative splicing and are found in the cell body and dendrites of neurons, with some isoforms also found in astrocytes and oligodendrocytes of the CNS and in the testis.1,2 MAP2 is expressed in mature neurons, with the MAP2a and MAP2c isoforms expressed in a developmental stage-dependent manner while the MAP2b isoform is expressed throughout development and adulthood.1,3 MAP2 binds to and stabilizes microtubules and increases their rigidity, as well as interacts with F-actin during neurite initiation and with proteins involved in signal transduction.2 Phosphorylation of the KXGS motif by MAP/microtubule affinity-regulating kinase 1 (MARK1), MARK2, or PKA decreases the affinity of MAP2 for microtubules, and the detachment of MAP2 leads to microtubule destabilization and disassembly. Decreased levels of MAP2 protein have been found in postmortem brain tissue from patients with a Lewy body variant of Alzheimer’s disease.4 MAP2 has been found in cytoplasmic neuronal Lewy bodies colocalized with α-synuclein and ubiquitin in postmortem substantia nigra from patients with Parkinson’s disease.5 Cayman’s MAP2 (human) Monoclonal Antibody can be used for immunocytochemistry (ICC), immunohistochemistry (IHC), and Western blot (WB) applications. The antibody recognizes MAP2 at approximately 280 kDa from human, mouse, and rat samples.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Kindler, S., and Garner, C.C. Four repeat MAP2 isoforms in human and rat brain. Brain Res. Mol. Brain Res. 26(1-2), 218-224 (1994).

    2. Dehmelt, L., and Halpain, S. The MAP2/Tau family of microtubule-associated proteins. Genome Biol. 6(1), 204 (2004).

    3. Cáceres, A., Banker, G.A., and Binder, L. Immunocytochemical localization of tubulin and microtubule-assocated protein 2 during the development of hippocampal neurons in culture. J. Neurosci. 6(3), 714-722 (1986).

    4. Melková, K., Zapletal, V., Narasimhan, S., et alStructure and functions of microtubule associated proteins tau and MAP2c: Similarities and differences. Biomolecules 9(3), 105 (2019).

    5. D'Andrea, M.R., Ilyin, S., and Plata-Salaman, C.R. Abnormal patterns of microtubule-associated protein-2 (MAP-2) immunolabeling in neuronal nuclei and Lewy bodies in Parkinson’s disease substantia nigra brain tissues. Neurosci. Lett. 306(3), 137-140 (2001).